<add><doc>
	<field name = "DATE">19-JUN-1987 14:18:34.08</field>
	<field name = "PLACES">usa</field>
	<field name = "UNKNOWN">F 
f1951reute
u f BC-GYNEX-GYNXU.O>-IN-DE   06-19 0066</field>
	<field name = "TITLE">GYNEX GYNXU.O> IN DEAL WITH WARNER WLA></field>
	<field name = "DATELINE">DEERFIELD, ILL., June 19 -</field>
	<field name = "BODY">Gynex Laboratories Inc said it
signed an agreement under which Warner-Lambert Co's Chilcott
Laboratories division will market Gynex's line of generic oral
contraceptives.
    Gynex Labs is a 50/50 joint venture owned by Gynex and
Watson Laboratories Inc, a privately-held pharmaceutical
company bnased on Corona, California.
    Marketing by Warner Chilcott is currently scheduled to
begin during the third quarter of 1987, it said.
    Gynex signed a similar marketing agreement with Monsanto
Co's MTC> G.D. Searle and Co subsidiary in February 1986,
which was terminated last April following a recall of the oral
contraceptives due to packaging problems.
 Reuter</field>
</doc></add>
